rametrixtech.com Open in urlscan Pro
216.252.195.134  Public Scan

Form analysis
1 forms found in the DOM

GET https://rametrixtech.com/

<form role="search" method="get" class="jet-search__form" action="https://rametrixtech.com/">
  <label class="jet-search__label">
    <input type="search" class="jet-search__field" placeholder="Search …" value="" name="s">
  </label>
  <button type="submit" class="jet-search__submit" aria-label="submit search"><span class="jet-search__submit-icon jet-blocks-icon"><i aria-hidden="true" class="fas fa-search"></i></span></button>
</form>

Text Content

Skip to content
John Robertson, CEO

(540) 239-0169
RobertsonJ@Rametrixtech.com

Request a demo
Request a demo
 * Home
 * About Us
   * About Rametrix® Technologies, Inc.
   * Our Team
 * Drug Checking
   * Controlled Substance Diversion
   * Substance Use Disorder
   * Chemotherapy Formulation
 * Disease Detection
   * Chronic Kidney Disease (CKD)
   * Urinalysis for CKD
   * Diabetic and Non-Diabetic Kidney Disease
   * Bladder Cancer
   * Molecular Urinalysis for Bladder Cancer
   * COVID19
 * Dialysis
 * Organ Transplantation
 * Products
   * Rametrix® AutoScanner V2.0™
   * ProofMed-CS™ Scanner V1.0
   * ProofMed-CH™ Scanner V1.0
 * Resources
 * Contact
 * ···
   * Contact



BREAKTHROUGH TEST FOR DETECTION OF CANCER IN DOGS ANNOUNCED

Read More


ABOUT RAMETRIX TECHNOLOGIES, INC. AND WHAT WE DO


A TRADITION OF EXCELLENCE



We analyze liquids and develop actionable information, based on the molecular
composition of the liquid.  Our focus on molecular urinalysis has provided
screening tools for important diseases, such as diabetes, chronic kidney
disease, and bladder cancer.



BACKGROUND

Starting with urinary tract diseases, we will empower doctors and patients to
make critical health care decisions through early, accurate, chronic disease
screening & detection in an affordable and efficient manner.



TECHNOLOGY

Our foundation is built on analytical devices and Artificial Intelligence
(AI)/Machine Learning.



RESULTS

 * Ability to detect, stage & monitor Chronic and Diabetic Kidney Disease
 * Detect, stage and monitor Bladder Cancer
 * Detect, stage, and monitor COVID19
 * Monitor effectiveness of hemodialysis in real-time



OUR MISSION

We will develop and use our cutting-edge, affordable technologies to improve
human and animal health, leading to a better quality of life for all.




DRUG DIVERSION

our servicesabout us

CHRONIC KIDNEY DISEASE

our servicesabout us


BLADDER CANCER

Our ServicesAbout Us



WE ARE RAMETRIX® TECHNOLOGIES, INC.

Every molecular fingerprint matters!

Request a Demo


WHY PEOPLE CHOOSE US


THOUSANDS OF SPECIMENS IN REFERENCE DATABASE


RESULTS IN
< 15 MINUTES


HIGHLY ACCURATE >90% SENSITIVITY/SPECIFICITY


DIRECT COST
< $1/ANALYSIS


RAMETRIX TECHNOLOGIES BRAND STORY


OUR CUSTOMERS


WHY PEOPLE CHOOSE US

All
Cancer Center
Transplant
Hospitals
Dialysis
Chemotherapy
Technician
Impurities

WAKE FOREST CANCER CENTER

CANCER CENTER

Analytical devices, like the ProofMed-CH™ V1.0 Scanner, help to assure patients
and their healthcare team that their chemotherapy doses are properly formulated
and free of impurities.

ORGAN TRANSPLANTATION MONITORING

TRANSPLANT

Rametrix® Technologies, Inc. computational technology is being used to determine
if organ transplants, such as kidneys, are functional in the critical days and
weeks following implantation.

CARILION

HOSPITALS

Ongoing studies of hospitalized COVID19 patients, using Rametrix® Molecular
Urinalysis, helps healthcare providers detect and intervene if potentially
significant kidney failure develops.

DIALYSIS MACHINE IN OPERATION

DIALYSIS

The Rametrix DialySensor V2.0 will be a key medical device for delivering
precision hemodialysis and improving patient outcomes and quality of life.”

CHEMOTHERAPY

CHEMOTHERAPY

The newly developed ProofMed-CH V1.0 Scanner will be used to determine if cancer
chemotherapy doses are correctly and safely formulated before administered to
critically-ill patients.

DR./TECHNICIAN LOOKING AT URINE SAMPLE

TECHNICIAN

Extensive studies of thousands of urine samples by Rametrix® Technologies, Inc.
scientists and engineers, in collaboration with collaborating physicians and
medical centers, have shown that serious health problems, like chronic kidney
disease, can be quickly detected with Rametrix® Technologies, Inc. Molecular
Urinalysis technology.

MOTHER HOLDING INFANT FEEDING FROM BOTTLE

IMPURITIES

Rametrix® Technologies, Inc. scientists and engineers are responding to recent
concerns over contaminated baby formula by developing procedures to detect
impurities quickly – during manufacturing.

WHY PEOPLE CHOOSE US

At Rametrix® Technologies, Inc. it is the expertise and enthusiasm of our Team
that empowers us to define and solve even the most difficult health and
analytical problems.


WE ARE RAMETRIX® TECHNOLOGIES, INC.

Every molecular fingerprint matters!

Request a demo

LATEST NEWS

BREAKTHROUGH TEST FOR DETECTION OF CANCER IN DOGS ANNOUNCED

Posted by Rametrix® Technologies, Inc.February 7, 2024
Rametrix Technologies, Inc., announced today that they have developed a
urine-based…

DIABETIC KIDNEY DISEASE DETECTION

Posted by Rametrix® Technologies, Inc.January 31, 2023
Analysis of urine Raman spectra differences from patients with diabetes
mellitus…

COVID-19 HOSPITALIZED PATIENT STUDY

Posted by Rametrix® Technologies, Inc.January 26, 2023
A study of 100 hospitalized COVID19 patient urine samples has shown…

ABOUT COMPANY



We analyze liquids and develop actionable information, based on the molecular
composition of the liquid. Our focus on molecular urinalysis has provided
screening tools for important diseases, such as diabetes, chronic kidney
disease, and bladder cancer.

CONTACT INFO

You can always contact with us via email or phone. Get in touch with contact and
get a quote form.
 * Address: 2000 Kraft Drive, Suite 1208
   Blacksburg, VA 24060
 * Custom Support & Sale: (540) 239-0169
 * E-mail: RobertsonJ@Rametrixtech.com

Home
About Us
Drug Checking
Disease Detection
Sales
Resources
Contact


RAMETRIX® TECHNOLOGIES, INC. ©. ALL RIGHTS RESERVED.